Funding for this research was provided by:
Innovative Medicines Initiative Joint Undertaking (EMIF grant agreement n° 115372)
NIH/NCI Cancer Center Support (P30 CA008748)
Polish Ministry of Science and Higher Education (DIR/WK/2017/01)
Received: 26 April 2018
Accepted: 31 July 2018
First Online: 28 August 2018
Ethics approval and consent to participate
: This study does not use or report any samples or data of individual subjects, and hence ethical consent is not applicable.
: Not applicable.
: PL received consultation and/or lecture honoraria from IBL International, Fujirebio Europe, AJ Roboscreen, and Roche. CT functioned in advisory boards of Fujirebio and Roche, received nonfinancial support in the form of research consumables from ADxNeurosciences and Euroimmun, and performed contract research or received grants from Probiodrug, Janssen Prevention Ca enter, Boehringer, Brainsonline, AxonNeurosciences, EIP farma, and Roche.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.